ulcerative colitis and semaglutide Crohn's Disease: Safety, Risks, and What Patients Should Know semaglutide and ulcerative colitis GLP-1

Popkin BM, DAnci KE, Rosenberg IH

What Both Medications Do Inside the Body Although the delivery systems differ, both medications activate the GLP-1 receptor and trigger similar downstream effects: Increased insulin release in response to elevated blood sugar Reduced glucagon secretion Slower gastric emptying Reduced appetite signaling Increased satiety after meals According to the National Institute of Diabetes and Digestive and Kidney Diseases, these mechanisms can support improved blood sugar regulation and meaningful weight reduction when combined with lifestyle interventions

Usually administered by a shot, the drug produces more insulin in the body to help lower blood sugar levels and ultimately help control type 2 diabetes

Routine monitoring of serum calcitonin or using thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with Ozempic Contraindications Ozempic is contraindicated in patients with a personal or family history of MTC or in patients with MEN 2, and in patients with a prior serious hypersensitivity reaction to semaglutide or to any of the excipients in Ozempic